These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25788109)

  • 1. Novel antigen delivery technologies: a review.
    Jain D; Jain V; Singh R
    Drug Deliv Transl Res; 2011 Apr; 1(2):103-12. PubMed ID: 25788109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine delivery--current trends and future.
    Azad N; Rojanasakul Y
    Curr Drug Deliv; 2006 Apr; 3(2):137-46. PubMed ID: 16611000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to vaccine delivery.
    O'Hagan DT; Rappuoli R
    Pharm Res; 2004 Sep; 21(9):1519-30. PubMed ID: 15497674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to pediatric vaccine delivery.
    O'Hagan DT; Rappuoli R
    Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges.
    Tlaxca JL; Ellis S; Remmele RL
    Adv Drug Deliv Rev; 2015 Oct; 93():56-78. PubMed ID: 25312673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
    Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
    Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine process technology.
    Josefsberg JO; Buckland B
    Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine delivery to animals.
    Bowersock TL; Martin S
    Adv Drug Deliv Rev; 1999 Jul; 38(2):167-194. PubMed ID: 10837755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses.
    Li N; Wang N; Wang X; Zhen Y; Wang T
    Drug Deliv; 2016 Nov; 23(9):3234-3247. PubMed ID: 26967666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
    Walker RI
    Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies.
    Brennan FR; Dougan G
    Vaccine; 2005 May; 23(24):3210-22. PubMed ID: 15837222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, stability, and delivery of live attenuated vaccines for human use.
    Burke CJ; Hsu TA; Volkin DB
    Crit Rev Ther Drug Carrier Syst; 1999; 16(1):1-83. PubMed ID: 10099898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antigen delivery systems.
    Trovato M; De Berardinis P
    World J Virol; 2015 Aug; 4(3):156-68. PubMed ID: 26279977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of Novel Materials and Advanced Genomic Technologies into New Vaccine Design.
    Liao W; Zhang TT; Gao L; Lee SS; Xu J; Zhang H; Yang Z; Liu Z; Li W
    Curr Top Med Chem; 2017; 17(20):2286-2301. PubMed ID: 28240182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
    Mrsny RJ
    J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.
    Wang S; Liu H; Zhang X; Qian F
    Protein Cell; 2015 Jul; 6(7):480-503. PubMed ID: 25944045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.